HeartSciences Inc. Common Stock (HSCS)
Stock · NASDAQ · Health Care
$3as of 10/16/2026
Price chart
Active signals
HSCS Signal Track Record
How signals performed across all stocks →What HSCS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 30 | +0.9% | 53% | October 5, 2026 |
| Bollinger Band Breakdown | 20 | -7.1% | 40% | July 28, 2026 |
| Bollinger Band Breakout | 16 | -9.9% | 31% | September 4, 2026 |
| 200-Day Moving Average TouchActive now | 7 | -3.3% | 29% | August 20, 2026 |
| Any 20-session window (baseline) | -8.7% | 34% |
Computed by MarketWall from daily closing prices since April 3, 2023. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About HSCS
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfuncti…
- Sector
- Health Care
- Industry
- Industrial Specialties
- Employees
- 14
- Website
- heartsciences.com/
Fundamentals
- 1-day range
- $2.89$3.24
- Market cap
- $7.80M
- P/E (trailing)
- —
- P/E (forward)
- -1.82
- EPS (trailing)
- $-3.21
- Dividend yield
- —
- Beta
- 1.78
- Avg. volume
- 157.9K
How HeartSciences Inc. Common Stock Makes Money
Where the revenue actually goes — FY2026 annual results
Source: 10-K filed Jul 23, 2026 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
HeartSciences Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- HSCSHeartSciences Inc. Common Stock$3.02▼ 5.03%Market cap $7.80MP/E —$1.63$5.25
- CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares$1.9▼ 2.56%Market cap $8.98MP/E —$1.45$14.8
- FGIFGI Industries Ltd. Ordinary Shares$7.49▼ 0.27%Market cap $9.13MP/E —$3.14$19.93
- CLGNCollPlant Biotechnologies Ltd Ordinary Shares$3.63▼ 1.49%Market cap $6.25MP/E —$2.64$26.8
- FEEDENvue Medical Inc. Common Stock$0.371▼ 24.29%Market cap $3.67MP/E —$0.2001$79.43
- COCHWEnvoy Medical Inc Warrant$0.0362▲ 10.03%Market cap $2.61MP/E —$0.02$0.095
- RGNTRegentis Biomaterials Ltd. Ordinary Shares$1.49▼ 3.87%Market cap $13.84MP/E —$1.23$15.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HSCS HeartSciences Inc. Common Stock | $7.80M | — | $3.02 | ▼ 5.03% | $1.63$5.25 |
| CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | $8.98M | — | $1.9 | ▼ 2.56% | $1.45$14.8 |
| FGI FGI Industries Ltd. Ordinary Shares | $9.13M | — | $7.49 | ▼ 0.27% | $3.14$19.93 |
| CLGN CollPlant Biotechnologies Ltd Ordinary Shares | $6.25M | — | $3.63 | ▼ 1.49% | $2.64$26.8 |
| FEED ENvue Medical Inc. Common Stock | $3.67M | — | $0.371 | ▼ 24.29% | $0.2001$79.43 |
| COCHW Envoy Medical Inc Warrant | $2.61M | — | $0.0362 | ▲ 10.03% | $0.02$0.095 |
| RGNT Regentis Biomaterials Ltd. Ordinary Shares | $13.84M | — | $1.49 | ▼ 3.87% | $1.23$15.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- FDA Grants 510(k) Clearance For HeartSciences’ MyoVista wavECGTM Device As 12-Lead Resting Electrocardiographbenzinga · 10/6/2026
- Fortitude Doubles Down on Zcash Mining With $100M BITMAIN CommitmentYahoo · 10/6/2026
- HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM DeviceYahoo · 10/6/2026
- FDA Grants 510(k) Clearance For HeartSciences’ MyoVista wavECGTM Device As 12-Lead Resting ElectrocardiographBenzinga · 10/6/2026
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga · 10/6/2026
- Why Option Care Health Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving PremarketBenzinga · 10/6/2026
- HeartSciences Files Prospectus Shelf Registration For $200M Mixed SecuritiesBenzinga · 9/25/2026
- Former Hut 8 CEO To Lead Crypto Miner FortitudeYahoo · 9/17/2026
- HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business UpdateYahoo · 9/15/2026
Insider Activity
Insider Actions →- Watson Danielle · July 7, 2026 · Grant25.0K
- Simpson Andrew · June 22, 2026 · Grant425.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 197.7K
- Total value held
- $494.5K
- Institutional holders
- 12
- Unknown76.5K
- Unknown29.7K
- Unknown28.9K
- Unknown18.9K
- Unknown17.2K
- Unknown16.8K
- Unknown6.5K
- Unknown2.1K
- Unknown700
- Unknown277
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
HeartSciences Files $200M Shelf Registration
HeartSciences Inc. has filed a prospectus to register up to $200 million of mixed securities on a shelf. The filing allows the company to issue shares, convertible notes, or other securities over a period of time. This move could give the company more flexibility to raise capital as needed. The filing is the first major corporate action reported in the past week.
HeartSciences Files $200M Shelf Registration. HeartSciences Inc. has filed a prospectus to register up to $200 million of mixed securities on a shelf. The filing allows the company to issue shares, convertible notes, or other securities over a period of time. This move could give the company more flexibility to raise capital as needed. The filing is the first major corporate action reported in the past week.